Trials / Completed
CompletedNCT00585637
Vitamin D for Chemoprevention
Defining Optimal Doses of Vitamin D for Chemoprevention in Blacks.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 328 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study will help us know the effects of Vitamin D pills in Blacks. The results of this study may be the first step in creating ways to prevent the risks of colon and prostate cancer. It will also help us develop ways to reduce colon cancer and prostate cancer among Blacks. This study will find out if Vitamin D pills can increase Vitamin D to healthy levels in our bodies.
Detailed description
* Participants will be asked to answer some questions about their diet, exercise and health. In addition, participants blood pressure will be taken. These assessments will occur at baseline, 3- and 6-month appointments. At baseline only, we will measure skin tone with a tool called the Photovolt 577. * A small blood sample will be taken to see how much Vitamin D is the body and will also look at levels of other markers of disease such as proteins, hormones, and genes. * Participants will take a vitamin pill every day for three months and be randomly assigned to one of four different types of pills. * Participants will be called or visited at least every two weeks. They will be asked questions to determine if they have any side effects associated with high levels of Vitamin D. * At the beginning of the second and third months, participants will be provided with more pills. At the end of the third month, another blood sample will be taken. Three months after that, the final blood sample will be taken.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D | Taken orally every day for three months |
| DIETARY_SUPPLEMENT | Placebo | Placebo pill taken once daily for 3 month |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2010-10-01
- Completion
- 2013-12-01
- First posted
- 2008-01-03
- Last updated
- 2015-04-01
- Results posted
- 2015-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00585637. Inclusion in this directory is not an endorsement.